FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

324180003: Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3678634011 Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3678636013 Erythromycin (as erythromycin stearate) 250 mg oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
56915901000001111 Erythromycin stearate 250mg tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

6 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Is a Product containing erythromycin in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has active ingredient Erythromycin stearate false Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has active ingredient Bactericide false Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Is a Product containing erythromycin stearate false Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has manufactured dose form Oral dose form false Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has active ingredient Erythromycin stearate false Inferred relationship Existential restriction modifier 1
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has basis of strength substance Erythromycin true Inferred relationship Existential restriction modifier 1
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has presentation strength numerator value 250 false Inferred relationship Existential restriction modifier 1
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has precise active ingredient Erythromycin stearate true Inferred relationship Existential restriction modifier 1
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Is a Product containing only erythromycin in oral dose form (medicinal product form) true Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Plays role Antibacterial therapeutic role true Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has manufactured dose form Oral dose form true Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has active ingredient Erythromycin false Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Erythromycin true Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has specific active ingredient Erythromycin stearate true Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has basis of strength substance Erythromycin false Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Erythromycin stearate 250mg tablet - product Is a False Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Erythromycin stearate 250mg tablets 28 tablet Has VMP True Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Erythromycin stearate 250mg tablets (Key Pharmaceuticals Ltd) Is a True Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Erythromycin stearate 250mg tablets (Alliance Healthcare (Distribution) Ltd) Is a True Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Erythromycin stearate 250mg tablets (Ennogen Pharma Ltd) Is a True Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Erythrocin 250 tablets (Abbott Laboratories Ltd) Is a True Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Erythrocin 250 tablets (CST Pharma Ltd) Is a True Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Erythromycin stearate 250mg tablets 500 tablet Is pack of False Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Erythromycin stearate 250mg tablets 100 tablet Is pack of False Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Erythromycin stearate 250mg tablets 500 tablet Has VMP True Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Erythromycin stearate 250mg tablets 100 tablet Has VMP True Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Erythrolar 250mg tablets (Ennogen Ltd) Is a True Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start